Bemærk: Kan ikke leveres før jul.
Forventes på lager: 27-11-2013
Here is a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled beta2 agonist for treating COPD. Covers design and pre-clinical pharmacology of the molecule, early clinical development, efficacy studies and more.
| Forlag | Springer Basel |
| Type | Bog |
| Format | Hardback |
| Sprog | Engelsk |
| Udgave | 2014 ed. |
| Udgivelsesdato | 27-11-2013 |
| Første udgivelsesår | 2013 |
| Serie | Milestones in Drug Therapy |
| Illustrationer | 21 Illustrations, color; 20 Illustrations, black and white; VII, 146 p. 41 illus., 21 illus. in color. |
| Fagredaktør | Alexandre Trifilieff |
| Originalsprog | Switzerland |
| Sideantal | 146 |
| Indbinding | Hardback |
| Forlag | Springer Basel |
| Sideoplysninger | 146 pages, 21 Illustrations, color; 20 Illustrations, black and white; VII, 146 p. 41 illus., 21 ill |
| Mål | 235 x 155 |
| ISBN-13 / EAN-13 | 9783034807081 |